Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Herbal melanin is a natural biological polymer and dark pigment extracted from the seed coat of *Nigella sativa* (black cumin). It primarily acts as an immunomodulator and gastroprotective agent by serving as a ligand for Toll-like receptors, particularly TLR4 and TLR2. Activation of these receptors triggers downstream signaling through NF-kappaB and MAPK pathways, leading to the modulation of pro-inflammatory and gastroprotective markers such as IL-6, IL-8, and PGE2. In oncology research, herbal melanin has demonstrated anti-proliferative and pro-apoptotic activity against various cancer cell lines, including breast and colorectal cancers, by upregulating p53 and Bax while downregulating anti-apoptotic proteins like Bcl-2 and Survivin. Clinical development has focused on its safety and efficacy in treating gastritis and dyspepsia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on herbal melanin.